MUST READ!!!

"IMPORTANT CHANGES AND REQUIREMENTS for PAs Prescription Drug Monitoring Program"

Recent enacted amendments to Maryland’s Prescription Drug Monitoring Program (PDMP) law has resulted in changes that affect the PA profession.

The attached PDMP Fact Sheet outlines information regarding new Mandatory Registration and Mandatory Use as well as other important changes.

Click to read more

Another Great Conference

2016 "Trends in Patient Management" Conference was once again a success!  We look forward to next year already.  Thanks to all that attended and to all that worked so hard to make this year a success!    Congrats to UMB/AACC  students for once again winning the "Golden Bedpan Award" during the Medical Challenge Bowl!

IMPORTANT ANNOUNCEMENT

NCCPA Responds to PA Concerns with Change to CME Requirements

At its meeting last weekend, the NCCPA Board of Directors responded to concerns from PAs and to a new analysis regarding the availability of self-assessment and PI-CME activities and reached a decision to relax the self-assessment and PI-CME requirements introduced with the new 10-year certification maintenance process.

Effective immediately, self-assessment CME and PI-CME are no longer required. However, in recognition of the value of these very interactive types of CME, NCCPA will weight those types of CME more heavily, awarding extra credit for these now optional types of CME.
“PAs have voiced concern about the cost and availability of self-assessment and PI-CME activities related to their practice, and the data support those concerns” said Denni Woodmansee, MS, PA-C, NCCPA Board chair.

Read more...

Legislative Update

Prescription

  It worked! As a result of your and AAPA’s advocacy efforts, the Senate HELP Committee will consider legislation tomorrow that will permit PAs and NPs to prescribe buprenorphine for the  treatment of opioid addiction.
 The amended TREAT Act (S. 1455) does not include a demonstration program. It amends federal law to
 affirmatively authorize PAs to prescribe buprenorphine, treating PAs, NPs, and physicians in the same
manner, while deferring to State law.
Before receiving a waiver to prescribe buprenorphine for the treatment of opioid addiction,
all qualified providers (PAs, NPs, and physicians) must complete 24 hours of training in the treatment and
management of opiate-dependent patients. AAPA is listed as one of the organizations who can provide
the training. Additionally, the Senate HELP Committee will consider Mental Health Reform legislation, which recognizes the interface between primary care and behavioral healthcare, as well as the critical role of PAs in behavioral healthcare through the following provisions:
*Includes PAs in the mental health career development strategic plan
*Acknowledges PAs among the healthcare providers who may serve on mental health/substance abuse advisory councils established through the legislation
*Identifies PAs with experience treating serious mental illness as potential members of a new Inter-Departmental Serious Mental Illness Coordinating Committee
*Adds PAs in the development of model programs and materials for training healthcare providers on appropriate disclosures to family, friends, or other caregivers of individuals suffering from mental illness or substance abuse disorders.

Again, thank you. Your advocacy made a difference. We look forward to continuing to work with you as this important legislation progresses.

Should you have any additional questions, comments or concerns please contact Sandy directly at sharding@aapa.org .

 

Recent Pictures

Recent News

Read More